The Biden administration is requiring federal employees to be fully vaccinated by Nov. 22. Regulators are drafting an emergency temporary standard that will implement a vaccine mandate for some 80 million private sector employees. (Reuters)

Data for Pfizer’s COVID-19 vaccine use in children under the age of 5 may be released in late October, CEO Albert Bourla said. Data for kids between 5 and 11, meanwhile, could be ready for submission to the Food and Drug Administration by the end of September. (CNBC Weekly)

A fourth boy has died in the Astellas-Audentes gene therapy trial, following the deaths of three other boys with myotubular myopathy. Astellas says the cause of death has yet to be determined, though the deaths have been linked to liver failure. (Endpoints News)

President Biden is calling on global leaders to commit to fully vaccinating 70% of the world’s population by September 2022. That goal is part of a list of objectives aiming to end the global pandemic. (The Washington Post)

Despite recent progress in gene therapy to treat sickle cell disease, federal underinvestment has led to delays in therapy approvals. To speed up the process, the National Institutes of Health is exploring ways to cover high costs of experimental sick cell therapies for clinical trial patients. (The New York Times)